Overview

Safety and Efficacy of Corneal Collagen Cross-linking Following LASIK for Treatment of Hyperopia and Hyperopic Astigmatism

Status:
Terminated

Trial end date:
2016-04-01

Target enrollment:

Participant gender:

Summary

The objectives of this study are to evaluate the safety and efficacy, with regards to regression of refractive outcome, as measured by manifest refraction spherical equivalent (MRSE), of two treatment regimens for hyperopic and hyperopic astigmatic subjects: LASIK followed by cross-linking performed with the KXL System and Photrexa ZD™ (Riboflavin Ophthalmic Solution), as compared to LASIK alone.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Avedro, Inc.
Glaukos Corporation

Treatments:

Dextrans
Ophthalmic Solutions
Pharmaceutical Solutions
Riboflavin